Esophageal Dysphagia Market Report 2025

This report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The esophageal dysphagia market size has grown strongly in recent years. It will grow from $2.08 billion in 2024 to $2.21 billion in 2025 at a compound annual growth rate (CAGR) of 6.1%. The growth in the historic period can be attributed to aging population, gastroesophageal reflux disease (gerd), advances in endoscopy, esophageal motility testing.

The esophageal dysphagia market size is expected to see strong growth in the next few years. It will grow to $2.88 billion in 2029 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to obesity epidemic, minimally invasive procedures, personalized medicine, global expansion of esophageal dysphagia care. Major trends in the forecast period include patient-centered care, telehealth and remote monitoring, nutritional support, research collaboration.

The increasing number of smokers is expected to drive the growth of the esophageal dysphagia market going forward. Smokers are individuals who habitually smoke tobacco products, including cigarettes, cigars, or pipes. Smoking can worsen esophageal dysphagia by causing irritation and damage to the esophagus, leading to various health complications. Treatment for esophageal dysphagia supports patients by enhancing nutrition and hydration, lowering the risk of aspiration, and improving quality of life. For example, in July 2022, the Cigar Association of America, a U.S.-based national trade association for the cigar industry, reported that the United States imported approximately 467.6 million premium cigars in 2023, reflecting a 0.7% increase over 2022. Thus, the rising number of smokers is fueling the esophageal dysphagia market.

The increasing prevalence of strokes is also expected to propel the growth of the esophageal dysphagia market. A stroke occurs when a blood vessel in the brain bursts or when blood flow to a part of the brain is obstructed. Stroke can impact brain regions responsible for swallowing, leading to esophageal dysphagia. For instance, in May 2023, Medical Xpress, a U.S.-based web-based medical and health news service provider, reported that worldwide stroke-related deaths are projected to reach nearly 5 million by 2030. Therefore, the growing incidence of strokes is contributing to the expansion of the esophageal dysphagia market.

Leading companies within the esophageal dysphagia market are actively engaged in the development of cutting-edge products that incorporate advanced technologies, such as pharyngeal electrical stimulation (PES) technology. These innovations are aimed at strengthening their relationships with existing customers. Pharyngeal electrical stimulation (PES) technology represents a therapeutic approach specifically designed to address certain swallowing disorders, notably dysphagia resulting from neurological conditions or related factors. As an illustration, in October 2022, Phagenesis Ltd., a UK-based company specializing in dysphagia care, introduced the Phagenyx neurostimulation system, built upon pharyngeal electrical stimulation technology. This system offers a novel rehabilitation treatment for post-stroke dysphagia by enhancing swallowing performance in individuals with neurogenic dysphagia associated with stroke. The method involves direct pharyngeal stimulation using location-specific intraluminal catheters introduced trans nasally. Furthermore, PES technology holds promise in enhancing the quality of life for dysphagia patients, reducing healthcare costs, and broadening its applicability to a wider spectrum of individuals with dysphagia.

In May 2023, Patheous Health Inc., a U.S.-based company specializing in dysphagia care, completed the acquisition of Carolina Speech Pathology LLC for an undisclosed sum. Through this strategic move, Patheous Health Inc. aims to broaden its reach, expand its array of services, and tap into additional talent, thereby gaining a competitive edge in the dysphagia healthcare market. Carolina Speech Pathology LLC is a U.S.-based developer of mobile dysphagia swallow imaging devices, designed to enhance esophageal dysphagia treatment.

Major companies operating in the esophageal dysphagia market are Nestle Health Science S.A., Novartis AG, Fresenius Kabi AG, Abbott Laboratories, Danone S.A., F. Hoffmann-La Roche Ltd., Merck Sharp and Dohme Corp., Pfizer Inc., Ingredion Incorporated, Eikonix Ltd., Olympus Corporation, Eisai Co. Ltd., Aurobindo Pharma Ltd., Dr. Reddys Laboratories, Cook Medical Incorporated, Elekta AB, Johnson and Johnson Ltd., C.R. Bard Inc., Avanos Medical Inc., Cipla Ltd., Kent Precision Foods Group Inc., Nutricia Ltd., CP Kelco Inc., Atos Medical AB, AstraZeneca PLC, NinePoint Medical Inc., Torax Medical Inc., Hormel Health Labs Inc., Dysphagia Management Systems LLC, Biostage Inc.

North America was the largest region in the esophageal dysphagia market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in esophageal dysphagia report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the esophageal dysphagia market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The esophageal dysphagia market consists of revenues earned by entities by providing services such as surgical assistance and physical therapy, clinical evaluation, impedance testing, dietary counseling and surgical interventions. The market value includes the value of related goods sold by the service provider or included within the service offering. The esophageal dysphagia market also includes the sales of feeding tubes, nasogastric tubes, nutritional solutions, thickeners, beverages, purees, dysphagia diets, esophageal dilation devices, surgical instruments, esophageal pH monitors, corticosteroids, antacids, proton-pump inhibitors (PPIs) and muscle relaxants. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

Esophageal dysphagia is a medical condition marked by difficulty in swallowing solid or liquid foods due to structural or functional abnormalities in the esophagus, lower esophageal sphincter (LES), or cardia. It can result from various underlying conditions that disrupt the normal functioning of the esophagus or impede the smooth passage of food and liquids.

The primary treatments for esophageal dysphagia encompass esophageal dilation, surgical intervention, stent placement, laparoscopic Heller myotomy, medications, and lifestyle adjustments. Esophageal dilation is a medical procedure employed to widen a narrowed or constricted segment of the esophagus, commonly used to address esophageal dysphagia stemming from esophageal strictures. Diagnosis of esophageal dysphagia can be achieved through dynamic swallowing studies, X-rays, endoscopy, manometry, imaging scans, including magnetic resonance imaging (MRI) and computed tomography (CT) scans. Various healthcare facilities, such as hospitals, clinics, ambulatory surgical centers, diagnostic centers, and research centers, serve as end-users for managing this condition.

The esophageal dysphagia market research report is one of a series of new reports that provides esophageal dysphagia market statistics, including esophageal dysphagia industry global market size, regional shares, competitors with an esophageal dysphagia market share, detailed esophageal dysphagia market segments, market trends and opportunities and any further data you may need to thrive in the esophageal dysphagia industry. This esophageal dysphagia market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.